New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines

Development of drug resistance is the main reason for low chemotherapy effectiveness in treating ovarian cancer. Paclitaxel (PAC) is a chemotherapeutic drug used in the treatment of this cancer. We analysed the development of PAC resistance in two ovarian cancer cell lines. Exposure of drug-sensitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Świerczewska, Monika, Klejewski, Andrzej, Brązert, Maciej, Kaźmierczak, Dominika, Iżycki, Dariusz, Nowicki, Michał, Zabel, Maciej, Januchowski, Radosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017641/
https://www.ncbi.nlm.nih.gov/pubmed/29649113
http://dx.doi.org/10.3390/molecules23040891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017641/
https://www.ncbi.nlm.nih.gov/pubmed/29649113
http://dx.doi.org/10.3390/molecules23040891

Ejemplares similares